Cargando…

Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study

BACKGROUND: To evaluate the effect of statin use on osteoarthritis (OA) incidence/progression using magnetic resonance imaging (MRI) in a population-based cohort with predominantly pre-radiographic knee OA. METHODS: A cohort aged 40–79 years with knee pain was recruited using random population sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Jagdeep, Sayre, Eric C., Guermazi, Ali, Nicolaou, Savvas, Cibere, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615180/
https://www.ncbi.nlm.nih.gov/pubmed/36307782
http://dx.doi.org/10.1186/s12891-022-05900-x
_version_ 1784820362772480000
author Gill, Jagdeep
Sayre, Eric C.
Guermazi, Ali
Nicolaou, Savvas
Cibere, Jolanda
author_facet Gill, Jagdeep
Sayre, Eric C.
Guermazi, Ali
Nicolaou, Savvas
Cibere, Jolanda
author_sort Gill, Jagdeep
collection PubMed
description BACKGROUND: To evaluate the effect of statin use on osteoarthritis (OA) incidence/progression using magnetic resonance imaging (MRI) in a population-based cohort with predominantly pre-radiographic knee OA. METHODS: A cohort aged 40–79 years with knee pain was recruited using random population sampling and followed for 7 years. Baseline exclusions were inflammatory arthritis, recent knee surgery/injury, and inability to undergo MRI. At baseline, current statin use was ascertained. Baseline and follow-up MRIs were read semi-quantitatively for cartilage damage (grade 0–4, 0/1 collapsed, 6 regions), osteophytes (grade 0–3, 8 regions), bone marrow lesions (BML) (grade 0–3, 6 regions) and effusion (grade 0–3). The primary outcome was cartilage damage incidence/progression, while secondary outcomes were incidence/progression of osteophytes, BML, and effusion, each defined as an increase by ≥1 grade at any region. To ensure population representative samples, sample weights were used. Logistic regression was used to assess the association of statin use at baseline with incidence/progression of MRI outcomes. Analyses were adjusted for sex, age, BMI, and multiple comorbidities requiring statin therapy. RESULTS: Of 255 participants evaluated at baseline, 122 completed the 7-year follow-up. Statin use was not significantly associated with progression of cartilage damage (OR 0.82; 95% CI 0.17, 4.06), osteophytes (OR 3.48; 95% CI 0.40, 30.31), BML (OR 0.61; 95% CI 0.12, 3.02), or effusion (OR 2.38; 95% CI 0.42, 13.63), after adjusting for confounders. CONCLUSION: In this population-based cohort of predominantly pre-radiographic knee OA, statins did not affect MRI incidence/progression of cartilage damage, BML, osteophytes or effusion. Therefore, statin use does not appear to affect people with pre-radiographic stages of knee OA.
format Online
Article
Text
id pubmed-9615180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96151802022-10-29 Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study Gill, Jagdeep Sayre, Eric C. Guermazi, Ali Nicolaou, Savvas Cibere, Jolanda BMC Musculoskelet Disord Research BACKGROUND: To evaluate the effect of statin use on osteoarthritis (OA) incidence/progression using magnetic resonance imaging (MRI) in a population-based cohort with predominantly pre-radiographic knee OA. METHODS: A cohort aged 40–79 years with knee pain was recruited using random population sampling and followed for 7 years. Baseline exclusions were inflammatory arthritis, recent knee surgery/injury, and inability to undergo MRI. At baseline, current statin use was ascertained. Baseline and follow-up MRIs were read semi-quantitatively for cartilage damage (grade 0–4, 0/1 collapsed, 6 regions), osteophytes (grade 0–3, 8 regions), bone marrow lesions (BML) (grade 0–3, 6 regions) and effusion (grade 0–3). The primary outcome was cartilage damage incidence/progression, while secondary outcomes were incidence/progression of osteophytes, BML, and effusion, each defined as an increase by ≥1 grade at any region. To ensure population representative samples, sample weights were used. Logistic regression was used to assess the association of statin use at baseline with incidence/progression of MRI outcomes. Analyses were adjusted for sex, age, BMI, and multiple comorbidities requiring statin therapy. RESULTS: Of 255 participants evaluated at baseline, 122 completed the 7-year follow-up. Statin use was not significantly associated with progression of cartilage damage (OR 0.82; 95% CI 0.17, 4.06), osteophytes (OR 3.48; 95% CI 0.40, 30.31), BML (OR 0.61; 95% CI 0.12, 3.02), or effusion (OR 2.38; 95% CI 0.42, 13.63), after adjusting for confounders. CONCLUSION: In this population-based cohort of predominantly pre-radiographic knee OA, statins did not affect MRI incidence/progression of cartilage damage, BML, osteophytes or effusion. Therefore, statin use does not appear to affect people with pre-radiographic stages of knee OA. BioMed Central 2022-10-28 /pmc/articles/PMC9615180/ /pubmed/36307782 http://dx.doi.org/10.1186/s12891-022-05900-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gill, Jagdeep
Sayre, Eric C.
Guermazi, Ali
Nicolaou, Savvas
Cibere, Jolanda
Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title_full Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title_fullStr Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title_full_unstemmed Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title_short Association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO): a cohort study
title_sort association between statins and progression of osteoarthritis features on magnetic resonance imaging in a predominantly pre-radiographic cohort: the vancouver longitudinal study of early knee osteoarthritis (valseko): a cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615180/
https://www.ncbi.nlm.nih.gov/pubmed/36307782
http://dx.doi.org/10.1186/s12891-022-05900-x
work_keys_str_mv AT gilljagdeep associationbetweenstatinsandprogressionofosteoarthritisfeaturesonmagneticresonanceimaginginapredominantlypreradiographiccohortthevancouverlongitudinalstudyofearlykneeosteoarthritisvalsekoacohortstudy
AT sayreericc associationbetweenstatinsandprogressionofosteoarthritisfeaturesonmagneticresonanceimaginginapredominantlypreradiographiccohortthevancouverlongitudinalstudyofearlykneeosteoarthritisvalsekoacohortstudy
AT guermaziali associationbetweenstatinsandprogressionofosteoarthritisfeaturesonmagneticresonanceimaginginapredominantlypreradiographiccohortthevancouverlongitudinalstudyofearlykneeosteoarthritisvalsekoacohortstudy
AT nicolaousavvas associationbetweenstatinsandprogressionofosteoarthritisfeaturesonmagneticresonanceimaginginapredominantlypreradiographiccohortthevancouverlongitudinalstudyofearlykneeosteoarthritisvalsekoacohortstudy
AT ciberejolanda associationbetweenstatinsandprogressionofosteoarthritisfeaturesonmagneticresonanceimaginginapredominantlypreradiographiccohortthevancouverlongitudinalstudyofearlykneeosteoarthritisvalsekoacohortstudy